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Tissue-type plasminogen activator (t-PA) has a high affinity for fibrin and induces lysis of fibrin (fibrinoly- 
sis) on the surface of fibrin without degrading circulating fibrinogen. cDNA for t-PA which lacks the ‘finger- 
domain’ (the site for fibrin affinity) was isolated from Detroit 562 cells. Analysis of the nucleotide sequence 
revealed a lack of the sequences which code for the finger-domain. A plasmid @DPAT 1) containing the 
Escherichia coli tat promoter/operator and the cDNA sequence coding for ‘finger-domain lacking t-PA’ 
was constructed for expression i E. Coli. The polypeptide so produced was a new type of t-PA lacking 
finger-domain, but revealed plasminogen activator activity with the function of fibrin affinity. 
Tissue-type plasminogen activator Finger-domain Fibrin affinity 
E. coli tat promoter/operator Detroit 562 cell 
1. INTRODUCTION 
t-PA has a high affinity for fibrin and induces 
fibrinolysis on the surface of fibrin without 
degrading circulating fibrinogen [ 1,2]. Administra- 
tion of t-PA to animals with experimentally in- 
duced thrombosis caused extensive thrombolysis 
without fibrinogenolysis [3,4]. Administration of 
t-PA in venous thrombosis [5] or acute myocardial 
infarction [6] in humans caused thrombolysis or 
reopening of the occluded vessels. Thus, t-PA in- 
duces a high ratio of fibrinolysis/fibrinogenolysis 
which is in contrast to the effect of the urinary 
plasminogen activator, UK. 
The primary structure of t-PA is quite different 
from that of UK: t-PA has 2 Kringle structures, 
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Abbreviations: t-PA, tissue-type plasminogen activator; 
UK, urokinase; S-225 1, H-D-valyl-L-leucyl-L-lysine- 
p-nitroanilide 
but UK only one [7,8]. Further, t-PA has a special 
domain termed the ‘finger-domain’ which is 
Plasmid 
responsible for the fibrin affinity [9]. We report 
here the isolation of cDNA for ‘finger-domain 
lacking t-PA’ from Detroit 562 cells and the ex- 
pression of finger-domain lacking t-PA in 
Escherichia co/i, using a plasmid containing the E. 
coli tat promoter/operator. 
2. MATERIALS AND METHODS 
2.1. Cloning 
A cDNA library was prepared from Detroit 562 
cells according to Okayama and Berg [lo]. Ap- 
prox. 100000 transformants of E. coli harboring 
the cDNA sequences were screened for com- 
plementarity to the following 2 synthetic 
oligonucleotide probes: probe I, 5’AATCGG- 
GCATGGATTTCCTG3 ’ and probe II, 5 ’ GCC- 
CCCGCACAGGAACCG3 ’ . The nucleotide ob- 
tained from clones reacting to both probes, was 
analyzed. 
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2.2. Construction of pDPAT 1 which expresses 
finger-domain lacking t-PA 
Plasmid pDPAT 1 (4.2 kb) was constructed by 
ligating pKIT 1 (2.4 kb) with pDPA 3 (5.1 kb). 
The plasmid pKIT 1 obtained in our laboratory 
(full details to be published) contains the tat pro- 
moter/operator and the SD sequence of C230 
(Pseudomonas putida metapyrocatechase). pKIT 1 
(2.5 pg) was digested with 15 units ClaI and 
dephosphorylated with calf intestine phosphatase. 
At the same time, pDPA 3 (5Opg) was digested 
with 150 units BgfiI and a 1800 base pair DNA 
fragment was isolated. After incubating this DNA 
fragment with 5 units DNA polymerase I (Klenow 
fragment) plus 40sM dGTP and dATP, 50 units 
Sl nuclease was reacted with the material. CIaI 
linker [d(CATCGATC)], whose 5 ’ -terminal was 
phosphorylated, was then linked to the above 
DNA fragment with T4 DNA ligase and subse- 
quently digested with ClaI. ATG sequence in the 
CIaI linker was used as initiative methionine, 
followed by serine residue at the 36th position. The 
final product derived from the DNA of pDPA 3 
was ligated to the DNA fragment derived from 
pKIT 1 with T4 DNA ligase and pDPAT 1 was ob- 
tained. The recombinant plasmid pDPAT 1 was 
used for transformation of JM 103, the well 
characterized lac I9 strain of E. coli. 
2.3. Measurement of fibrinolytic activity 
The fibrinolytic activity of the cell homogenate 
was examined by 3 methods. (i) Amidolytic activity 
[ 111. S-2251, which is a plasmin substrate, was 
reacted with a mixture of the sample and purified 
plasminogen in the presence of fibrinogen- 
fragment. (ii) Fibrinolytic activity [12]. The 
fibrinolytic activity was estimated by the fibrin 
film method, for which bovine plasminogen-rich 
fibrinogen and bovine thrombin were employed. 
(iii) Electrophoretic enzymography [131. To iden- 
tify the molecular mass of the enzymatically active 
component, the sample was first electrophoresed 
under non-reduced conditions in SDS-poly- 
acrylamide gel and the fibrin film produced as 
above was then overlayered on the gel. 
2.4. Binding of tissue-type plasminogen activator 
lacking finger-domain to a fibrin-celite 
column 
Transformed E. coli JM 103 containing the 
plasmid of pDPAT 1 was incubated in LB medium 
and the cell pellet obtained by centrifugation was 
sonicated in an ultrasonifier. After centrifugation, 
the supernatant produced was dissolved in 50% 
(NH&S04 and precipitated at 10000 rpm for 
30 min. The pellet was dissolved in 50 mM Tris- 
HCl (pH 7.4), with 0.01% Tween 80, and acidified 
to pH 5.2. After 30 min incubation at 4°C and 
centrifugation, the neutralized solution was ap- 
plied to anti-t-PA IgG Sepharose which was pro- 
duced with a monoclonal antibody to t-PA [14]. 
The bound protein was eluted with 6 M guanidine 
hydrochloride and the plasminogen activator ac- 
tivity was measured. The bound t-PA was eluted 
completely with 6 M guanidine hydrochloride and 
no activity was eluted with 2 M KSCN. The frac- 
tion with t-PA activity was pooled and applied to 
a fibrin-celite column. The unbound portion and 
the protein eluted with 0.2 M arginine were used 
for measurement of the plasminogen activator 
activity. 
3. RESULTS 
3.1. Cloning and expression of finger-domain 
lacking t-PA 
Among 100000 clones, 15 showed a positive 
hybridized signal to one of the probes and only one 
clone, x1776 (pDPA 3), to both probes. The 
nucleotide sequence of pDPA 3 was determined 
and the amino acid sequence was deduced from it 
(fig.1). The cDNA sequence comprised 2459 base 
- 
Fig. 1. Sequence of human tissue-type plasminogen activator lacking the finger-domain, with nucleotides numbered in 
the 5’- to 3’-direction, beginning with the dC residue. The predicted protein sequence is shown above the DNA. The 
numbers in the right-hand column indicate the amino acid residues, beginning with the first residue of the ATG triplet 
encoding the initial methionine. The sequences homologous to the synthetic oligonucleotide probes I and II are 
underlined (nucleotides 225-244 for probe I, and 1032-1049 for probe II). The complete DNA sequence of the protein 
coding region of the tissue-type plasminogen activator was in part determined from genomic clones. Capital letters 
indicate putative amino acids; small letters indicate the putative ‘prepro’ region. Arrows indicate the cleavage sites for 
BgllI. 
146 
Volume 189, number 1 FEBS LETTERS September 1985 
i 50 
met asp ala met lys 
TCTGCGAGGAAAGGGAAGGAGCAAGCCGTGAATTTT~GGGACGC~TG~~C~~ATG GAT GCA ATG AAG 
Iii0 150 
leu Lcu leu oys gly ala v.11 pllc val ser pro ser gln glu ilc his ala arg phe 
CTG CTG CTG TGT GGA GCA G'TC TTC GTT TCG CCC ACC CAG GAA ATC CAT GCC CGA TTC 
200 
arg gly leu cys cys val 11 
AGA GGG CTC TGC TGT GTG 
TYR GLN GLY CYS SER GLU PRO ARG CYS PHE ASN GLY GLY THR CYS GLN GLN ALA LEU 
TAC CAA GGT TGC AGC GAG CCA AGG TGT TTC AAC GGG GGC ACC TGC CAG CAG GCC CTG 
300 
CYS GLN CYS PRO GLU GLY PIIE ALA GLY LYS CYS CYS GLU ILE ASP THR ARG ALA TIIR CYS TYR GLU ASP GLN GLY 86 
TGC CAG TGC CCC GAA GGA TTT GCT GGG AAG TGC TGT GAA ATA GAT ACC AGG GCC ACG TGC TAC GAG GAC CAG GGC 
350 450 
ILE SER TYR ARG GLY THR TRP SER TIIR ALA GLU SER GLY ALA GLU CYS THR ASN TRP 
ATC AGC TAC AGG GGC ACG TGG AGC ACA GCG GAG AGT GGC GCC GAG TGC ACC AAC TGG 
450 
GLN LYS PRO TYR SER GLY ARG ARG PRO ASP ALA ILE A 'G LEU GLY LEU GLY ASN HIS 
CAG AAG CCC TAG AGT GGG CGG AGG CCA GAC GCC ATC ! A G CTG GGC CTG GGG AAC CAC 
500 
ASP ARG ASP SER LYS PRO TRP CYS TYR VAL PUE LYS ALA GLY LYS TYR SER Sl?R GLU 
GAT CGA GAC TCA AAG CCC TGG TGC TAC GTC TTT AAG GCG GGG AAG TAC AGC TCA GAG 
600 
CYS SER GLU GLY ASN SER ASP CYS TYR PHE GLY ASN GLY SER ALA TYR ARG GLY THR HIS SER LEU THR GLU SER 186 
TGC 'I-CT GAG GG& AAC AGT GAC TGC TAC TTT GGG AAT GGG TCA GCC TAC CGT GGC ACG CAC AGC CTC ACC GAG TCG 
650 700 
GLY ALA SER cys Lsu PRO TRP ASN SER NET ILE,LE~ ILE GLY ~ys VAL TYR TUR ALA 
GGT GCC TCC TGC CTC CCG TGG AAT TCC ATG ATC CTG &TA GGC AAG GTT TAC ACA GCA 
750 
ALA LEU GLY LEU GLY LYS HIS ASN TYR CYS ARG ASN PRO ASP GLY ASP ALA LYS PRO TRP CYS HIS VAL LEU LYS236 
GCA CTG GGC CTCj GGC AAA CAT AAT TAC TGC CGG AAT CCT GAT GGG GAT GCC AAG CCC TGG TGC CAC GTG CTG AAG 
no0 350 
arg arg gly ala arg SER 36 
AGA AGA GGA GCC A TCT 
LSO 
TYR PHE SER ASP P-HE VAL 61 
TAC TTC TCA GAT TTC GTG 
ASN SER SER ALA LEU ALA 111 
AAC AGC AGC GCG TTG GCC 
ASN TYR CYS ARG ASN PRO 136 
AAC T&C TGC AGA AAC CCA 
550 
PllE CYS SER THR PRO ALA 161 
TTC TGC AGC ACC CCT GCC 
GLN ASN PRO SER ALA GLN 211 
CAG AAC CCC AGT GCC CAG 
ASN ARG ARG LEU THR TRP GLU TYR CYS ASP VAL PRO SER CYS SER THR CYS GLY LEU 
AAC CGC AGG CTG ACG TGG GAG TAC TGT GAT GTG CCC 'ECC TGC TCC ACC TGC GGC CTG 
900 
ARG GLN TYR SER GLN PRO261 
AGA CAG TAC AGC CAG CCT 
GLN PIIE ARG ILE LYS GLY GLY LEU PHE ALA ASP ILE ALA SER HIS PRO TRP GLN ALA 
CAG TTT CGC ATC AAA GGA GGG CTC TTC GCC GAC An: GCC TCC CAC CCC TGG CAG GCT 
950 
ALA ILE PNE ALA LYS HIS 286 
GCC ATC TTT GCC AAG CAC 
1000 
ARC ARG SER PRO GLY GLU ARG PIIE LEU CYS GLY GLY ILE LEU ILE SER SER CYS TRP ILE LEU SER ALA ALA HIS 311 
AGG AGG TCG CCC GGA GAGEGG TTC CTG TGC GGG a &TA CTC ATC AGC TCC TGC TGG ATT CTC TCT GCC GCC CAC 
1050 
CYS PIIE GLN GLU ARG PHE PRO PRO HIS HIS LEU THR VAL ILE LEU GLY ARG THR TYR ARG VAL VAL PRO GLY GLU 336 
TGC TTC CAG GAQ AGG TTT CCG CCC CAC CAC CTG ACG GTG ATC TTG GGC AGA ACA TAC CGG G'EG GTC CCT GGC GAG 
1100 1150 
GLU GLU GLN LYS PIIE GLU VAL GLU LYS TYR ILE VAL HIS LYS GLU PHE ASP ASP ASP THR TYR ASP ASN ASP ILE 361 
GAG GAG CAG AAA TTT GAA GTC GAA AAA TAC ATT GTC CAT AAG GAA TTC GAT GAT GAC ACT TAC GAC AAT GAC ATT 
1200 
ALA LEU LEU GLN LEU LYS SER ASP SER SER ARG CYS ALA GLN GLU SER SER VAL VAL ARG TNR VAL CYS LEU PRO 306 
GCG CTG CTG CAG CTG AAA TCG GAT TCC TCC CGC TGT GCC CAG GAG AGC AGC GTG GTC CGC ACT GTG TGC CTT CCC 
1250 1300 
PRO GLU ASP LEU GLN LEU PRO ASP TRP THR GLU CYS GLU LEO SER GLY TYR GLY LYS HIS GLU ALA till SER PRO 411 
CCG GAG GAC CTG CAG CTG CCG GAC TGG ACG GAG TGT GAG CTC TCC GGC TAC GGC AAG CAT GAG GCC TTG TCT CCT 
1350 
PHE TYR SER GLU ARG LEU LYS GLU ALA HIS VAL ARG LEU TYR PRO SER SER ARG CYS THR SER GLN HIS LEU LEU436 
TTC TAT TCG GAG CGG CTG AAG GAG GCT CAT GTC AGA CTG TAC CCA TCC AGC CGC TGC ACA TCA CAA CAT TTA CTT 
1400 1450 
ASN ARG THR VAL TBR ASP ASN MET LEU CYS ALA GLY ASP TIIR ARG SER GLY GLY PRO GLN ALA ASN LEO HIS ASP 461 
AAC AGA ACA GTC ACC GAC AAC ATG CTG TGT GCT GGA SAC ACT CGG AGC GGC GGG CCC CAG GCA AAC TTG CAC GAC 
1500 
ALA CYS GLN GLY ASP SER GLY GLY PRO LEU VAL CYS LEU ASN ASP GLY ARG MET TUR LEU VAL GLY ILE ILE SER466 
GCC TGC CAG GGC CAT TCG GGA GGC CCC CTG GTG TGT CTG AAC GAT GGC CGC ATG ACT TTG GFG GGC ATC ATC AGC 
1550 1600 
TRP GLY LEU GLY CYS GLY GI,N LYS ASP VAL PRO GLY VAL TYR THR LYS VAL TllR ASN TYR LEU ASP TRP ILE ARC 511 
TGG GGC CTG GGC TGT GGA CAG AAG GAT GTC CCG GGT GTG TAC ACC AAG GTT ACC AAC TAC CTA GAC TGG ATT CGT 
1650 
ASP ASN NET ARG PRO XXX 
GAC AAC ATG CGA CCG TGA CCAGGAACACCCGACTCC~CAAAAGCARAn;AGATCCCGCC~~T~TTCAG~GACACTGC~GGCGCAGT 
1700 1750 
GCTTCTCTACAGACTTCTCCAGACCCACCACACCGCAGNI 
1800 11350 
GAAGTTTTCAGGACTTGGTCn;ATTTTCAGGATAC~TGTCAGA~GG~GACA~~TGCACACTAGCC~C~CAGGAATGCC~C~CC~G~AGM 
1900 1 ‘) 5 0 
Gn;GCCATGCCACCCTGTTTTCGCTAAAGCTAAAGCCTT 
2800 3ii50 
AGTAAAAGATAAC GATCTTTCAGGAAAGACGGATPGCATTAGAAATTA~ATAGACAGTATA~TATAGTCACAA~AGCCCAGCAGG~~~G~~~A 
"i 2100 2150 
GGCTGGCTGGCCCGTCAn;TTCCTCAAAAGCACCCTTGACGTC~GTCTCCT~CCCTTTCCCCAC~CCTGGC~~~~~TA~CTT~~TA 
LZIIIJ 2i50 
CAGn;TGTAAAGTGTAAATCCTTTTTCTTCTTTAT~CTTTAGAGTAGCA~AGAG~~GTA~AT~~C~~TAG~T~AGCATA~ATAGCMT 
2300 1350 
CCAn;TTAGTTTTTACTTTCTGTTGCCACAACCCCTGTTTTATACTGTACTT~T~T~AGATATA~T~A~AG~~C 
2400 2350 
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pairs except the dG-dC and dA-dT stretches, and 
one long open reading frame of 1548 base pairs in 
which a code of 5 16 amino acids was included. The 
sequences were very close to that reported 
previously for t-PA 171, but the molecular mass of 
the sequence was similar to that of UK (53 kDa) 
and not to that of t-PA (70 kDa). The smaller 
molecular mass reflected the lack of 138 base pairs 
which code for the finger-domain (fig.2). 
The nucleotide sequences coding for the putative 
mature finger-domain lacking t-PA were expressed 
in E: coli. Briefly, a 1.8 kb BgfiI fragment which 
codes for the putative mature polypeptide, was ex- 
cised from pDPA 3, and ligated with the plasmid 
pKIT 1 which is an expression vector derived from 
pBR 322 containing the tat promoter/operator 
system. Since microheterogeneity was observed in 
the N-terminal region of previously reported 
amino acid sequences for t-PA [15,16], the amino 
acid in the 36 position, Ser, was tentatively 
adopted as the N-terminal amino acid of the ex- 
pressed finger-domain lacking t-PA. 
3.2. Plasmi~ogen activator activity of finger- 
domain lacking t-PA 
The fibrinolytic activity of the cell homogenate, 
E. coli JM 103, was examined by 3 methods, as 
outlined above. The cell homogenate revealed 
S-2251 catalytic activity in a dose-dependent man- 
ner in the presence of purified plasminogen and 
fibrinogen-fragment. Plasminogen activator was 
500 ,000 1500 2000 2500 
ACAQQAGTC 
(TTCTQAQCA) 
Fig.2. Specific regions of tissue-type plasminogen 
activator. The cross-hatched region indicates the coding 
sequence of the putative mature tissue-type plasminogen 
activator (481 amino acids). The stippled region 
represents the putative 35-residue ‘prepro’ peptide 
coding sequences. (A) Deletion of base pairs; capital 
letters, substituted bases from those of t-PA obtained 
from melanoma cells (parentheses). 
z 0.10. 0.2M Arg 
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Fig.3. Binding of tissue-type plasminogen activator 
lacking finger-domain to a fibrin-celite column. The 
unbound protein had no plasminogen activator activity, 
but the eluted protein with 0.2 M arginine demonstrated 
clear t-PA activity. 
also observed by the standard fibrin film method. 
Electrophoretic enzymography demonstrated a 
lytic zone at an Mr of 55 000, which was close to the 
Mr of UK. This value for the molecufar mass fitted 
well with that calculated on the basis of the 
number of amino acid residues (481). 
3.3. Fibrin affinity of finger-domain lacking t-PA 
The fibrin affinity was investigated by purifying 
the plasminogen activator using monoclonal an- 
tibody of t-PA, and the eluted plasminogen ac- 
tivator fraction was applied to fibrin-celite col- 
umn. Although the unbound fraction did not 
reveal any fibrinolytic activity, the elution fraction 
with 0.2 M Arg demonstrated plasminogen ac- 
tivator activity (fig.3). Thus, the plasminogen ac- 
tivator which was lacking in the finger-domain 
showed an affinity for fibrin as well as 
plasminogen activator activity. 
4. DISCUSSION 
t-PA has a high affinity for fibrin [1,2] and the 
mechanism of expression of the fibrin affinity at 
the molecular level has been reported to involve a 
finger-domain in the N-terminal region which is 
responsible for such biological characteristics [9]. 
Since UK, another plasminogen activator, does not 
display any fibrin affinity, the molecular structure 
of t-PA has been extensively studied. This study 
was undertaken to clarify the mechanism of the 
fibrin affinity of the t-PA molecule by producing . _ 
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finger-domain lacking t-PA in E. co&. A cDNA 
library was prepared from Detroit 562 cells and 
transformants of E. coii which showed a positive 
hybridization signal to 2 synthetic oligonucleotide 
probes were screened (pDPA 3). Analysis of the 
nucleotide sequence revealed one long open 
reading frame of 1548 base pairs which coded for 
5 16 amino acids (fig. I), of which the sequence was 
close to t-PA [7]. However, one exceptional 
feature was that the nucleotide sequence lacked 
138 base pairs which code for the finger-dom~n in 
the t-PA structure (fig.2). These missing base pairs 
corresponded exactly to the exon IV noted in the 
structure of the t-PA gene [17]. Exon V was thus 
directly connected to exon III. Such novel joining 
of exons III and V resulted in a glycine residue 
(amino acid number 39 in fig.1) at the junction 
site. The deletion of 138 base pairs may imply that 
alternative splicing of RNA occurs in Detroit 562 
cells. However, the possibility cannot be excluded 
that these cells possess an altered genomic 
structure. 
A plasmid containing the B co& fat pro- 
moter/o~rator and the cDNA sequence coding 
for finger-domain lacking t-PA was constructed 
for expression in E. co&. The polypeptide pro- 
duced in E. coii (which carries no carbohydrate) 
demonstrated plasminogen activator activity which 
was examined by 3 methods. The molecular mass 
of the plasminogen activator was 55 kDa, which 
was close to that of UK, and not to that of native 
t-PA, the carbohydrate content of which was 6.8% 
(w/w) [15]. This molecular mass also fitted well to 
that calculated on the basis of the number of 
amino acid residues (481). The fibrin affinity was 
examined using the purified pl~minogen activator 
and it was found that the plasminogen activator 
which lacked the finger-domain still had fibrin af- 
finity (fig.3). 
Induction of fibrinolysis only on the surface of 
fibrin by t-PA represents one of the most signifi- 
cant findings in recent research on blood 
fibrinolysis [l-3]. The mechanism underlying the 
fibrin affinity of t-PA still remains unclear. The 
finger-domain has been reported to be responsible 
for the fibrin affinity of t-PA [9]. However, the ex- 
pression of fibrin affinity of t-PA lacking the 
finger-dom~n as observed in this study suggests 
that the finger-domain is not a prerequisite for the 
expression of fibrin affinity in the t-PA molecule. 
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